Works about TOLL-like receptor agonists
Results: 99
Impact of an Injectable Trace Mineral Supplement on the Immune Response and Outcome of Mannheimia haemolytica Infection in Feedlot Cattle: Impact of an Injectable Trace Mineral Supplement on the Immune Response and Outcome of Mannheimia haemolytica Infection in Feedlot Cattle: S. Hong et al
- Published in:
- Biological Trace Element Research, 2025, v. 203, n. 3, p. 1475, doi. 10.1007/s12011-024-04251-z
- By:
- Publication type:
- Article
From silent partners to potential therapeutic targets: macrophages in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 4, p. 1, doi. 10.1007/s00262-025-03965-w
- By:
- Publication type:
- Article
Structure‐Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400429
- By:
- Publication type:
- Article
Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals.
- Published in:
- Journal of Drug Targeting, 2024, v. 32, n. 9, p. 1052, doi. 10.1080/1061186X.2024.2384071
- By:
- Publication type:
- Article
Generating bat primary and immortalised cell-lines from wing biopsies.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-76790-3
- By:
- Publication type:
- Article
Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67000-1
- By:
- Publication type:
- Article
CRX-527 as a candidate adjuvant in a recombinant BCG-based malaria vaccine.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2024, v. 14, n. 1, p. 1, doi. 10.4103/2221-1691.393581
- By:
- Publication type:
- Article
Activin A increases phagocytosis of Escherichia coli K1 by primary murine microglial cells activated by toll-like receptor agonists.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling.
- Published in:
- Cell Biochemistry & Biophysics, 2024, v. 82, n. 4, p. 3015, doi. 10.1007/s12013-024-01418-2
- By:
- Publication type:
- Article
Quercetin inhibits NF-kB and JAK/STAT signaling via modulating TLR in thymocytes and splenocytes during MSG-induced immunotoxicity: an in vitro approach.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09245-7
- By:
- Publication type:
- Article
MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52863-9
- By:
- Publication type:
- Article
An in situ depot for the sustained release of a TLR7/8 agonist in combination with a TGFβ inhibitor promotes anti-tumor immune responses.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50967-w
- By:
- Publication type:
- Article
Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/7692973
- By:
- Publication type:
- Article
Canine Adipose Tissue Stem Cells Induced With Toll-Like Receptor Agonists Exhibit Antibacterial Activity Against Multi Drug Resistant Pathogens.
- Published in:
- Kafkas Universitesi Veteriner Fakultesi Dergisi, 2023, v. 29, n. 2, p. 151, doi. 10.9775/kvfd.2022.28863
- By:
- Publication type:
- Article
Virus-like nanoparticle vaccines for inducing long-lasting immunity against infectious diseases.
- Published in:
- National Science Review, 2024, v. 11, n. 4, p. 1, doi. 10.1093/nsr/nwae032
- By:
- Publication type:
- Article
The Expression of Toll-like Receptors in Cartilage Endplate Cells: A Role of Toll-like Receptor 2 in Pro-Inflammatory and Pro-Catabolic Gene Expression.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 17, p. 1402, doi. 10.3390/cells13171402
- By:
- Publication type:
- Article
Continuing Effect of Cytokines and Toll-Like Receptor Agonists on Indoleamine-2,3-Dioxygenase-1 in Human Periodontal Ligament Stem/Stromal Cells.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 12, p. 2696, doi. 10.3390/cells9122696
- By:
- Publication type:
- Article
SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 8, p. 1310, doi. 10.3390/v16081310
- By:
- Publication type:
- Article
Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 5, p. 1198, doi. 10.3390/v15051198
- By:
- Publication type:
- Article
Toll-like receptor 2-mediated ERK activation significantly upregulates interleukin-6 expression in M2-polarized macrophages.
- Published in:
- Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2024, v. 49, n. 6, p. 748, doi. 10.1515/tjb-2024-0105
- By:
- Publication type:
- Article
Effects of early treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on the bronchoalveolar lavage proteome and oxylipids during bovine respiratory syncytial virus (BRSV) infection.
- Published in:
- PLoS ONE, 2024, v. 19, n. 11, p. 1, doi. 10.1371/journal.pone.0309609
- By:
- Publication type:
- Article
An adjuvant formulation containing Toll-like Receptor 7 agonist stimulates protection against morbidity and mortality due to Anaplasma marginale in a highly endemic region of west Africa.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0306092
- By:
- Publication type:
- Article
Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-05853-y
- By:
- Publication type:
- Article
Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth.
- Published in:
- Journal of Drug Targeting, 2021, v. 29, n. 7, p. 754, doi. 10.1080/1061186X.2021.1878364
- By:
- Publication type:
- Article
Regional modulation of toll‐like receptor signaling pathway genes in acute epididymitis in mice.
- Published in:
- Andrology, 2024, v. 12, n. 5, p. 1024, doi. 10.1111/andr.13630
- By:
- Publication type:
- Article
All-Natural Gelatin-Based Nanoemulsion Loaded with TLR 7/8 Agonist for Efficient Modulation of Macrophage Polarization for Immunotherapy.
- Published in:
- Nanomaterials (2079-4991), 2024, v. 14, n. 19, p. 1556, doi. 10.3390/nano14191556
- By:
- Publication type:
- Article
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1530262
- By:
- Publication type:
- Article
Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1462221
- By:
- Publication type:
- Article
Editorial: Novel adjuvant systems that generate pathogen specific T cell responses following immunization for infectious disease vaccine formulations.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1467461
- By:
- Publication type:
- Article
The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1407649
- By:
- Publication type:
- Article
Sulforaphane diminishes moonlighting of pyruvate kinase M2 and interleukin 1β expression in M1 (LPS) macrophages.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2022.935692
- By:
- Publication type:
- Article
Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155668
- By:
- Publication type:
- Article
Differential modulation of toll-like receptor agonists-induced iNOS expression by polyunsaturated and saturated fatty acids.
- Published in:
- Food & Agricultural Immunology, 2017, v. 28, n. 6, p. 1071, doi. 10.1080/09540105.2017.1326468
- By:
- Publication type:
- Article
Study on the mechanism of action of Wu Mei Pill in inhibiting rheumatoid arthritis through TLR4-NF-κB pathway.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2024, p. 1, doi. 10.1186/s13018-024-04551-z
- By:
- Publication type:
- Article
FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.
- Published in:
- Radiation Research, 2024, v. 201, n. 5, p. 449, doi. 10.1667/RADE-23-00142.1
- By:
- Publication type:
- Article
Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays.
- Published in:
- BMC Infectious Diseases, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12879-025-10577-3
- By:
- Publication type:
- Article
Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
- Published in:
- In Vivo, 2024, v. 38, n. 4, p. 1636, doi. 10.21873/invivo.13613
- By:
- Publication type:
- Article
Pentraxin-3 is a novel marker for the diagnosis of endometriosis.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
New horizons in cancer immunotherapy: The evolving role of R848 and R837 (Review).
- Published in:
- Molecular & Clinical Oncology, 2025, v. 22, n. 1, p. N.PAG, doi. 10.3892/mco.2024.2799
- By:
- Publication type:
- Article
Toll-like receptor 3: a double-edged sword.
- Published in:
- Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00739-5
- By:
- Publication type:
- Article
Eradication of proliferative verrucous leukoplakia with toll-like receptor 7 agonist (topical imiquimod): a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1473889
- By:
- Publication type:
- Article
Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1488527
- By:
- Publication type:
- Article
Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2899, doi. 10.1007/s00213-019-5176-9
- By:
- Publication type:
- Article
Carvedilol alleviates the detrimental effects of azathioprine on hepatic tissues in experimental rats: Focusing on redox system, inflammatory and apoptosis pathways.
- Published in:
- Human & Experimental Toxicology, 2024, v. 43, p. 1, doi. 10.1177/09603271241269003
- By:
- Publication type:
- Article
“Immunopeeling” Using Imiquimod for Xeroderma Pigmentosum.
- Published in:
- Indian Dermatology Online Journal, 2024, v. 15, n. 4, p. 673, doi. 10.4103/idoj.idoj_446_23
- By:
- Publication type:
- Article
Prunella vulgaris polysaccharide inhibits herpes simplex virus infection by blocking TLR-mediated NF-κB activation.
- Published in:
- Chinese Medicine, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13020-023-00865-y
- By:
- Publication type:
- Article
Retraction Note: The Protective Role of Toll-Like Receptor Agonist Monophosphoryl Lipid A against Vaccinated Murine Schistosomiasis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice